Back to Search
Start Over
Editorial: Engineered medicines to mitigate resistance to cancer immunotherapy.
- Source :
-
Frontiers in medicine [Front Med (Lausanne)] 2024 Aug 06; Vol. 11, pp. 1452812. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Details
- Language :
- English
- ISSN :
- 2296-858X
- Volume :
- 11
- Database :
- MEDLINE
- Journal :
- Frontiers in medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39165370
- Full Text :
- https://doi.org/10.3389/fmed.2024.1452812